Microbix Biosystems (TSE:MBX) Stock Price Passes Above 50 Day Moving Average – What’s Next?

Microbix Biosystems Inc. (TSE:MBX) passed above its 50 day moving average during trading on Thursday . The stock has a 50 day moving average of C$0.23 and traded as high as C$0.26. Microbix Biosystems shares last traded at C$0.25, with a volume of 70,034 shares changing hands.

Microbix Biosystems Price Performance

The company has a 50 day moving average of C$0.23 and a 200-day moving average of C$0.24. The stock has a market capitalization of C$34.64 million, a P/E ratio of -8.33 and a beta of 0.40. The company has a quick ratio of 5.57, a current ratio of 7.51 and a debt-to-equity ratio of 30.47.

Microbix Biosystems (TSE:MBX) last released its quarterly earnings data on Thursday, February 12th. The company reported C($0.01) EPS for the quarter. The business had revenue of C$4.22 million during the quarter. Microbix Biosystems had a negative return on equity of 14.88% and a negative net margin of 25.48%. Sell-side analysts predict that Microbix Biosystems Inc. will post 0.02 EPS for the current year.

Microbix Biosystems Company Profile

Microbix develops proprietary biological technology solutions for human health and well-being, with about 90 skilled employees and sales growing from a base of over $1 million per month. It makes a wide range of critical biological materials for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products that support clinical lab proficiency testing, assay development and validation, or clinical lab workflows.